TEI Biosciences Awarded Contract By Health Resource Services (HRS), An Amerinet Affiliate, To Bring Biologic Mesh Products To 150 Acute Care And Teaching Hospitals In More Than 20 States

WALTHAM, Mass., May 12, 2015 /PRNewswire/ -- TEI Biosciences Inc. ("TEI"), a leading biomedical company that applies its expertise in regenerative medicine to develop and commercialize novel biologic devices for a broad spectrum of soft tissue repair and regeneration applications, announced today that it has signed an agreement with Health Resource Services, LLC (HRS), an Amerinet Affiliate, for its SurgiMend® Collagen Matrix for Soft Tissue Reconstruction. The three-year agreement is effective May 1, 2015 and will make SurgiMend available to the HRS network, which includes over 150 acute care and teaching hospitals in more than 20 states throughout the country.  The HRS announcement follows TEI's February announcement of its three-year contract award with Novation, the nation's leading health care services company.

"The HRS contract award recognizes, once again, the strong value proposition of our SurgiMend product family to our customers and their patients," said Yiannis Monovoukas, PhD, MBA, TEI's Chairman, President and CEO. "This partnership with HRS will provide significant cost savings to their entire network, while allowing ever more patients to benefit from our proven regenerative platform technology," added Dr. Monovoukas.

About SurgiMend and SurgiMend PRS

SurgiMend and SurgiMend PRS are acellular collagen matrices designed specifically for plastic and reconstructive surgery and hernia repair, and are made of pure collagen that provides weakened and damaged tissues sound support for rapid healing without inflammation. They are derived from young bovine dermis, one of the richest sources of Type III collagen available. Type III collagen mediates tissue healing and growth while inhibiting scarring. Intraoperatively, the matrix is seeded with the patient's tissue-building cells and growth factors, and is rapidly revascularized to support healing, tissue building, and prolonged reinforcement.

About TEI Biosciences Inc.

TEI Biosciences, based in Waltham, MA, is a privately-held, leading biomedical company that applies its expertise in regenerative medicine to develop and commercialize novel biologic devices for a broad spectrum of soft tissue repair and regeneration applications from dura and hernia repair to plastic and reconstructive surgery.

TEI Biosciences sells its products directly and through partnerships with some of the world's major medical device companies. TEI Biosciences' marketed products include:

• SurgiMend^® and SurgiMend^® PRS for plastic and reconstructive surgery, soft tissue reconstruction, hernia repair, and muscle flap reinforcement
• Durepair^® for cranial dura repair (marketed by Medtronic)
• Xenform for pelvic floor reconstruction (marketed by Boston Scientific)

About Health Resource Services, LLC (HRS), an Amerinet Affiliate

The HRS network includes over 150 acute care and teaching hospitals in 20+ states throughout the country.  HRS has been providing quality group purchasing services to medical providers and suppliers for over 25 years.  http://amerinet-hrs.com/

For more information, contact Raoul Verheggen, Director of Marketing, at rverheggen@teibio.com or (617) 268-1616 x243, or visit us at www.teibio.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tei-biosciences-awarded-contract-by-health-resource-services-hrs-an-amerinet-affiliate-to-bring-biologic-mesh-products-to-150-acute-care-and-teaching-hospitals-in-more-than-20-states-300081379.html

SOURCE TEI Biosciences Inc.